Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: Regulation of cyclin-dependent kinases CDK2 and CDK1

Biochemical Pharmacology

Volumn 61, Issue 10, 2001, Pages 1205-1215

  Casagrande, Fabrice ^a   Darbon, Jean Marie ^a  

^a Université de Toulouse Paul Sabatier   (France)

Author keywords

Cell cycle; Cyclin dependent kinase; Flavonoids; Melanoma cells; Proliferation

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; AMINO ACID; ANTIBODY; ANTINEOPLASTIC AGENT; APIGENIN; CATECHIN; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; DAIDZEIN; FLAVONOID; GENISTEIN; HESPERETIN; HYDROXYL GROUP; KAEMPFEROL; LUTEOLIN; NARINGENIN; PROTEIN P21; PROTEIN P27; QUERCETIN; TAXIFOLIN;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MELANOMA; MELANOMA CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

CDC2 PROTEIN KINASE; CDC2-CDC28 KINASES; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; FLAVONOIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MELANOMA; MICROTUBULE-ASSOCIATED PROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 0035874028     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00583-4     Document Type: Article

References (52)

1. The impact of plant flavonoids on mammalian biology: Implication for immunity, inflammation and cancer
2. Soy intake and cancer risk: A review of the in vitro and in vivo data
3. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms
4. Suppression of tumour development by substances derived from the diet mechanisms and clinical implications
5. Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin
6. Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice
7. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis
8. Genistein exerts multiple suppressive effects on human breast carcinoma cells
9. Prooxidant states and tumor promotion
10. Effect of structurally related flavones/isoflavones on hydrogen peroxide production and oxidative DNA damage in phorbol ester-stimulated HL-60 cells
11. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis
12. Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cells
13. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells
14. Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships
15. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: A comparison with tyrosine kinase and protein kinase C inhibition
16. Genistein, a specific inhibitor of tyrosine-specific protein kinases
17. Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonine protein kinases
18. Flavonoids and the inhibition of PKC and PI 3-kinase
19. Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity
20. Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cells
21. Genistein arrests cell cycle progression at G2-M
22. The effect of quercetin on cell cycle progression and growth of human gastric cancer cells
23. Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors
24. Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle
25. Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468
26. Flavonoids activate wild-type p53
27. Growth-inhibitory effect of tamoxifen and quercetin and presence of type II estrogen binding sites in human laryngeal cancer cell lines and primary laryngeal tumors
28. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells
29. The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells
30. Inhibition of growth and induction of differentiation of metastatic melanoma cells in vitro by genistein: Chemosensitivity is regulated by cellular p53
31. CIP1 is dispensable for the G2 arrest caused by genistein in human melanoma cells
32. Cip1/WAF1 expression and blocks the G1 to S phase transition in mouse fibroblast and melanoma cells
33. Apigenin induces morphological differentiation and G2-M arrest in rat neuronal cells
34. The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes
35. Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin
36. Cyclins and cyclin-dependent kinases: A biochemical view
37. Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells
38. Inhibitors of mammalian G1 cyclin-dependent kinases
39. Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275
40. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase CDK2 and CDK4 in human breast carcinoma cells
41. KIP1 and inhibition of G1 CDKs in choroidal melanoma cells
42. Promoter activation and following induction of the p21/WAF1 gene by flavone is involved in G1 phase arrest in A549 lung adenocarcinoma cells
43. WAF1/CIP1 mRNA and protein expression during liver regeneration after partial hepatectomy
44. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein
45. Genistein induces maturation of cultured human breast cancer cells and prevents tumor growth in nude mice
46. Distinct Chk2 activation pathways are triggered by genistein and DNA-damaging agents in human melanoma cells
47. WAF1/CIP1 induction, G2/M arrest, and apoptosis
48. Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells
49. WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells
50. WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line
51. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells
52. Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: Implications for prostate cancer intervention